PDL BIOPHARMA

Details for Australian Trade Mark No. 1083266 (hide)

Owner PDL Biopharma, Inc.

Convention US 9 May 2005 78/625553

Service Davies Collison Cave

Various Convention priority claimed: 9 May 2005, United States of America, No. 78/625553, 78/625560 and 78/625566.* Provisions of paragraph 44(3)(b) applied.

Filing Date 28 October 2005

Classes

Class 5 Pharmaceutical preparations, including those for the treatment, prevention and diagnosis of allergies, autoimmune deficiencies, cardiovascular, inflammatory, ophthalmic, oncological, and organ transplant-related conditions and diseases

Class 16 Printed educational materials, namely pamphlets, booklets and brochures concerning the treatment, prevention and diagnosis of diseases, including allergies, autoimmune deficiencies, cardiovascular, inflammatory, ophthalmic, oncological, and organ transplanted-related conditions and diseases

Class 42 Scientific and medical research in the fields of drug development and testing; scientific and medical research in the fields of disease prevention, diagnosis and treatment

Event Publications

17 November 2005 Application filed

16 November 2006 Application Accepted

1 February 2007 Application/IR Name Amendment and Changes

  The owner's/holder's name has been changed to PDL Biopharma, Inc..

15 March 2007 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1083267-OPTIO

1083265